A Multicenter, Open-Label Study of Tapentadol Extended-Release Tablets in Opioid-Naïve and Opioid-Switching Subjects With Moderate to Severe Cancer Pain

Palliative Care Research
doi 10.2512/jspm.11.147
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society for Palliative Medicine

Related search

PSY5 a Systematic Review of Tapentadol in Chronic Moderate to Severe Pain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Tapentadol Extended-Release for Treatment of Chronic Pain: A Review

Journal of Pain Research
AnesthesiologyPain Medicine
2011English

OnabotulinumtoxinA Treatment of Moderate to Severe Glabellar Lines in Chinese Subjects After Laser Therapy: A Prospective, Open-Label, Noncomparative Study

Journal of Cosmetic and Laser Therapy
DermatologyMedicineSurgery
2018English

Injectable Extended-Release Naltrexone for the Prevention of Relapse to Opioid Dependence Following Opioid Detoxification

Neuropsychiatry
PsychiatryMental HealthNeurology
2012English

Opioid Rotation With Extended-Release Opioids: Where Should We Begin?

International Journal of General Medicine
Medicine
2011English

Opioid Combination for Cancer Pain

British Journal of Cancer
Cancer ResearchOncology
2004English

Combatting Pain After Orthopedic/Trauma Surgery- Perioperative Oral Extended-Release Tapentadol vs. Extended-Release Oxycodone/Naloxone

BMC Anesthesiology
AnesthesiologyPain Medicine
2017English

Opioid Dose Titration for Severe Cancer Pain: A Systematic Evidence-Based Review

Journal of Palliative Medicine
MedicineAnesthesiologyPain MedicineNursing
2004English

Effectiveness and Safety of Morphine Sulfate Extended-Release Capsules in Patients With Chronic, Moderate-To-Severe Pain in a Primary Care Setting

Journal of Pain Research
AnesthesiologyPain Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy